Zobrazeno 1 - 8
of 8
pro vyhledávání: ''
Publikováno v:
Chest. 146:1159-1165
BACKGROUND Hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) are involved in the pathogenesis of various lung diseases. This study was designed to determine the possible interactions of these growth factors in the developme
Publikováno v:
Chest. 147:e134-e136
Diffuse alveolar hemorrhage (DAH) is a syndrome caused by different mechanisms, including capillary stress failure, diffuse alveolar damage, and capillaritis. Capillaritis is the most common cause and is often associated with systemic autoimmune diso
Autor:
Charles L. Daley, Michael S. Stulbarg, Richard J. Wallace, Theodore K. Marras, Clayton T. Cowl, Laura L. Koth
Publikováno v:
Chest. 127:664-671
Background Hypersensitivity pneumonitis has been described with exposure to aerosolized Mycobacterium avium complex (MAC) in indoor hot tubs (hot tub lung). Objectives To describe a case of MAC-associated hypersensitivity pneumonitis-like reaction po
Publikováno v:
Chest. 141(2)
Mucinous bronchioloalveolar carcinoma (BAC) can be associated with significant bronchorrhea. A 46-year-old man presented with BAC with 2,000 mL of sputum production on a daily basis, which prevented him from being extubated. As this condition is rare
Autor:
Hyeon Kyoung Koo, Ji Yeon Lee, Seo Yun Kim, Yeon Joo Lee, Jae Ho Lee, Jin-Haeng Chung, Ho Il Yoon, Sung Soo Park, Choon-Taek Lee
Publikováno v:
Chest. 139(3)
Propylthiouracil (PTU) is a drug used to treat hyperthyroidism. A number of adverse effects have been reported with this drug, including fever, agranulocytosis, skin rash, and vasculitis. PTU-induced interstitial pneumonia is rare--only three cases h
Autor:
Khaled Eissa, Jaime Palomino
Publikováno v:
Chest. 146:385A
Interstitial lung disease (ILD) is a major cause of morbidity and mortality in patients with idiopathic inflammatory myopathies (IIM). Glucocorticoids are the initial standard treatment. However, many patients fail to respond and continue to progress
Publikováno v:
Chest. 120(1)
Background: Low-dose erythromycin therapy improves airflow limitation and airway inflammation in patients with diffuse panbronchiolitis (DPB). However, to our knowledge there has been no study to determine whether physiologic improvement during eryth
Publikováno v:
Chest. 113(5)
To evaluate the relationship between alveolar macrophage (AM) elastase and plasminogen activator (PA) activities (considered to be potential pathogenetic factors in emphysema) and the development of emphysema in smokers.Thirty-four healthy smokers35